Dallah Healthcare appoints Moteb Al-Tukhais as new CEO

Dallah Healthcare Company has announced that its board of directors has accepted the resignation of Chief Executive Officer and Investment and Finance Committee member Ahmed BaBaair, citing personal reasons. The resignation will take effect on September 1, 2026. The board also approved the appointment of Moteb bin Abdullah Al-Tukhais as CEO and as a member of the Investment and Finance Committee, effective the same date.

The board of directors and all employees of Dallah Healthcare expressed their deep gratitude and appreciation to Dr. BaBaair, commending his dedicated efforts and leadership over the past eighteen years. They highlighted his significant contributions, which have advanced the group’s operational excellence, sustainable growth, and established its position as a leading medical institution in the Kingdom. They wished him continued success in his future endeavors.

Al-Tukhais was selected to lead the executive management based on his extensive leadership and strategic experience within the organization. He has served as Chief Strategy Officer since 2022 and previously led the company’s Strategy and Project Management Office from 2017 to 2022, directly contributing to the development and execution of the group’s growth, expansion, and investment partnership plans.

Al-Tukhais brings over 15 years of experience in corporate strategy, major capital project management, and mergers and acquisitions. He also has broad expertise serving on boards and specialized committees and overseeing strategic investments.

He holds a master’s degree in project management from Heriot-Watt University in the UK and a bachelor’s degree in civil engineering from King Saud University. He has also completed several advanced executive programs at leading global academic institutions, including the Mergers and Acquisitions Program at Harvard University and specialized executive and financial programs at London Business School.

Dallah Healthcare affirmed that this smooth leadership transition underscores its continued commitment to ambitious expansion plans, enhancing operational efficiency, and delivering the highest standards of comprehensive healthcare in line with its strategy and the aspirations of its employees and investors.